House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled study

2000156 citationsJournal Article

Authors

C. Vatrinet · Stallergenes Greer (France)

Abstract

We conclude that SLIT in rhinitis caused by house-dust mite was safe, but there was a lack of consistent clinical benefit compared to placebo, probably due to the impact of the allergen avoidance measures that lowered the allergen burden.

Topics & Keywords

Allergic Rhinitis and Sensitization Asthma and respiratory diseases Dermatology and Skin Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Allergy

Volume 55, Issue 4, pp. 369-375

DOI: 10.1034/j.1398-9995.2000.00413.x

Field-Weighted Citation Impact: 3.98